WHWK
Whitehawk Therapeutics, Inc.
3.50$
+1.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
Whitehawk Therapeutics, Inc. (WHWK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -15 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.5 | -1.9 | -3.0 | -3.3 | 11 | -3.2 | -17 | -12 | -19 | -11 | -8.2 | -11 | -21 | -17 | -12 | -9.6 | -20 | -9.2 | -16 | -15 | -12 | -53 | -15 | -17 | -22 | -15 | -69 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.6 | 1.4 | 1.8 | 2.2 | 2.8 | 2.9 | 2.7 | 3.1 | 3.0 | 3.1 | 3.6 | 2.8 | 2.6 | 1.9 | 1.7 | 3.1 | 2.7 | 2.4 | 2.2 | 1.5 | 8.8 | |
| 0.6 | 0.2 | -1.2 | -11 | 14 | 0.6 | -4.9 | 2.0 | -7.5 | 1.4 | 3.7 | 0.6 | -7.8 | 4.0 | 0.0 | -1.0 | 2.0 | 0.3 | 0.6 | 0.8 | 0.7 | -3.4 | 0.2 | 4.5 | 1.6 | 0.9 | 7.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.1 | 0.1 | 1.4 | 0.7 | 1.1 | 0.8 | 0.7 | 0.5 | 0.2 | 0.2 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | – | -0.2 | 25 | 0.0 | 0.0 | -0.2 | -48 | -84 | 16 | 51 | 13 | 3.6 | 11 | -3.6 | 5.1 | 13 | 115 | -29 | -92 | 17 | 19 | -17 | -72 | |
| – | – | – | – | – | – | 4.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.0 | 0.2 | 0.0 | – | – | 0.0 | 142 | 0.1 | 0.3 | -0.1 | 73 | -0.1 | 0.0 | 0.3 | -0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 95 | -0.9 | 0.0 | 0.0 | 0.0 | 82 | 82 | |
| 12 | -1.7 | -3.0 | -3.3 | 11 | -3.3 | 150 | -12 | -19 | -11 | 16 | -96 | -5.0 | 34 | 0.6 | -5.9 | -9.1 | -13 | -11 | -1.9 | 199 | -83 | -107 | -0.4 | -2.8 | 50 | -60 | |
| -4.5 | -1.9 | -3.0 | -3.3 | 11 | -3.2 | -17 | -12 | -19 | -11 | -8.3 | -11 | -23 | -17 | -13 | -10 | -20 | -9.7 | -16 | -15 | -12 | -53 | -15 | -17 | -22 | -15 | -69 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.